ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "interferons and systemic sclerosis"

  • Abstract Number: 1727 • ACR/ARHP Annual Meeting 2017

    Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of Interferon-Associated Genes in CD4+ and CD8+ T Cells

    Weilin Pu1, Weifeng Ding2, Lei Wang3, Shuai Jiang4, Wenzhen Tu3, Shicheng Guo5, Qingmei Liu6, Yanyun Ma4, Sidi Chen7, Wenyu Wu6, Xiaodong Zhou8, Maureen D. Mayes9, Shervin Assassi9, John D. Reveille9, Li Jin10 and Jiucun Wang10, 1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences,, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China, 2Medical Laboratory Center, Medical Laboratory Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China, Nantong, China, 3Division of Rheumatology, Division of Rheumatology, Shanghai TCM-integrated Hospital, Shanghai, China, Shanghai, China, 4Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China, Shanghai, China, 5Department of Bioengineering, Department of Bioengineering, University of California at San Diego, CA, USA, San Diego, CA, 6Department of Dermatology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China, 7State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences,, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China, 8Internal Medicine-Rheumatology, University of Texas McGovern Medical School, Houston, TX, 9University of Texas McGovern Medical School, Houston, TX, 10State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China

    Background/Purpose: Systemic sclerosis (SSc) is a complex systemic autoimmune disease caused by complicated interaction between genetic, epigenetic and environmental risk factors. Evidence showed epigenetic modifications,…
  • Abstract Number: 2927 • ACR/ARHP Annual Meeting 2017

    Interferon Regulatory Factor (IRF) 7 in Type I IFN Signaling Represents As a Key Upstream Regulator in Early Diffuse SSc Patients and Plays Critical Role in Pathogenesis of Fibrosis

    Minghua Wu1, Gloria Salazar1, Jun Ying1, Julio Charles2, Xiaodong Zhou3, Maureen D. Mayes2 and Shervin Assassi2, 1Department of Internal Medicine - Rheumatology, University of Texas McGovern Medical School, Houston, TX, 2University of Texas McGovern Medical School, Houston, TX, 3Internal Medicine-Rheumatology, University of Texas McGovern Medical School, Houston, TX

    Background/Purpose: Previous global gene expression studies of SSc patients revealed presence of a prominent type I interferon (IFN) signature. IRF7 is a key transcription factor…
  • Abstract Number: 2902 • ACR/ARHP Annual Meeting 2013

    Key Roles For Interferon and Macrophage Activation In Progressive Lung Fibrosis Associated With Systemic Sclerosis

    Romy Christmann1, Giuseppina Stifano2, Claudia Borges3, Carlos Carvalho4, Ronaldo Kairalla4, Edwin R. Parra5, Avrum Spira6, Robert W. Simms1, Percival Sampaio-Barros7, Vera L. Capelozzi5 and Robert Lafyatis1, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2Rheumatology, Boston University Medical Center, Boston, MA, 3Rheumatology, CEUMA University, Sao Luis do Maranhao, Brazil, 4Pulmonology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, 5Pathology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, 6Computational Biomedicine, Boston University School of Medicine, Boston, MA, 7Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil

    Background/Purpose: Interstitial lung disease associate with Systemic Sclerosis(SSc-ILD) is one of the leading causes of mortality. We analyzed the gene expression of lung tissue in…
  • Abstract Number: 2914 • ACR/ARHP Annual Meeting 2013

    Serum Proteins and Whole Blood Transcripts Suppressed By An Anti-Type I Interferon Receptor Monoclonal Antibody In Subjects With Systemic Sclerosis

    Xiang Guo1, Brandon W. Higgs2, Christopher Kane3, Chris, A. Morehouse2, Zheng Liu2, Liangwei Wang4, Stephen Yoo5, Yihong Yao2, Lorin Roskos6 and Wendy White7, 1Translational Sciences, MedImmune LLC, Gaithersburg, MD, 2Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 3MedImmune, LLC, Gaithersburg, MD, 4Biostatistics, MedImmune, LLC, Gaithersburg, MD, 5Clinical Development, MedImmune, LLC, Gaithersburg, MD, 6One MedImmune Way, Medimmune, Gaithersburg, MD, 7Translational Sciences, MedImmune, Gaithersburg, MD

    Background/Purpose: To identify serum markers that are modulated by an investigational human IgG1κ monoclonal antibody directed against subunit 1 of the type I interferon receptor…
  • Abstract Number: 2290 • ACR/ARHP Annual Meeting 2012

    Type I Interferon Associated Gene IRF7 in the Pathogenesis of Fibrosis in Systemic Sclerosis (SSc)

    Minghua Wu1, Michael R. Blackburn2, Shervin Assassi1, Xiaochun Liu1, John D. Reveille1, Filemon K. Tan1, Sandeep K. Agarwal3 and Maureen D. Mayes1, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, TX, 3Medicine, Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX

    Background/Purpose: Fibrosis in Systemic Sclerosis is characterized by excessive collagen production and accumulation in the skin and lungs. It has been increasingly appreciated that a…
  • Abstract Number: 2301 • ACR/ARHP Annual Meeting 2012

    The Interferon Type I Signature Is Increased in Monocytes From Systemic Sclerosis Patients

    Zana Brkic1, Lenny van Bon2, Cornelia G. van Helden-Meeuwsen3, Madelon C. Vonk4, Hanneke Knaapen5, Wim van den Berg5, Paul L. Van Daele3, Virgil A. Dalm1, Timothy Radstake2 and Marjan A. Versnel1, 1Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Utrecht/Radboud University Nijmegen Medical Center, Utrecht/Nijmegen, Netherlands, 3Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 4Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 5Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

    Background/Purpose: Systemic sclerosis (SSc) is a complex fibrosing disease of unknown etiology. The past decade clear indications for an aberrant immune system have been revealed.…
  • Abstract Number: 1474 • ACR/ARHP Annual Meeting 2012

    Interferon-Inducible Chemokines Correlate with Disease Severity in Systemic Sclerosis

    Xiaochun Liu1, Maureen D. Mayes1, Filemon K. Tan1, Minghua Wu1, John D. Reveille2, Brock E. Harper3, Hilda T. Draeger4, Emilio B. Gonzalez5 and Shervin Assassi6, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, 3Int Med/Rheumatology, University of Texas Medical Branch, Galveston, TX, 4Med/Clinical/Immunology, Univ of TX Health Sci Ctr, San Antonio, TX, 5Rheumatolgoy/Dept Int Med, University of Texas Medical Branch, Galveston, TX, 6Rheumatology, Univ of Texas Health Science Houston, Houston, TX

    Plasma Interferon Inducible Chemokine Score: Stable Marker of Disease Severity in Systemic SclerosisABSTRACT:Background/Purpose: The most prominent gene expression profile in the peripheral blood of patients…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology